Revlon

Dermatologist Pamela Wexler, MD, Beth Israel Medical Center, signs agreement to consult on the "development and promotion" of new skin care and cosmetics products slated to bow in late 2000 and early 2001, the company announces June 28. Wexler is a member of the American Board of Dermatology and American Board of Internal Medicine. The products will contain Senetek's patented Kinetin technology; Revlon signed a $3 mil. licensing agreement with Senetek in June (1"The Rose Sheet" June 19, In Brief)